SlideShare ist ein Scribd-Unternehmen logo
1 von 31
Downloaden Sie, um offline zu lesen
FIGHTING DRUG-RESISTANT MALARIA
Read the daily message and record notes of
important points and deliverables. (5 min)
Open your pinned Daily Message Notes
• Add the today’s date and the subject of the
message (Causes of Drug Resistance) at the
top of the note.
• Add (Copy/Paste) summary of deliverables
and/or important information under heading.
NSEI 1.3.1 WARM-UP
NSEI REVIEW NS IN PARASITES
Interns re-watch a video to review what you have learned about parasite populations and
antimalarial drugs. (5 min)
What have you learned about antimalarial drug resistance? Share with your table.
NSEI REVIEW NS IN PARASITES
Key Points:
• Antimalarial drugs act as a selection pressure on a population of malaria parasites.
• Every time a malaria parasite reproduces, a mutation that could lead to resistance to a
drug has a chance to occur.
• A mutation can result in a new trait that is adaptive or non-adaptive, or the mutation may
have no noticeable effect.
• Parasites with the adaptive trait of drug resistance will be more likely to survive the
exposure to that drug and be able to reproduce and pass this trait to their offspring.This
shifts the distribution of traits in that population, so that many more individual parasites
have resistance for that drug.
• In the presence of this selection pressure, the distribution of traits in a population of
malaria parasites may shift toward increased drug resistance.
NSEI 1.3.2 READING
ANTIMALARIAL DRUG RESISTANCE
Interns actively read from the Dossier to learn more about how single-drug and combination
treatments affect drug resistance. (25 min)
Open the Futura Biomedical Engineer’s Dossier.
Selecting the link in the Daily Message and use the
table of contents to navigate to Ch 4: “Antimalarial
Drug Resistance.”
• Today’s research connects what you have learned
about antimalarial drugs as a selection pressure to
how drug resistance develops in a diverse
population of parasites.
• You should make annotations that help answer the
question on the board: How do malaria treatments
influence drug resistance?
NSEI 1.3.2 READING
ANTIMALARIAL DRUG RESISTANCE
Read and annotate independently.
Actively read and annotate Ch.4
“Antimalarial Drug Resistance” of the
Dossier.
• Carefully review the diagrams and
captions, and to look at the glossary if
you need more support with
engineering and project terms.
NSEI 1.3.2 READING
ANTIMALARIAL DRUG RESISTANCE
Share and discuss your annotations
with your partner.
Talk about what you have learned from the
chapter.
What ideas do you have about how
antimalarial drugs influence drug resistance?
NSEI 1.3.2 READING
ANTIMALARIAL DRUG RESISTANCE
Let’s review the diagrams to check for understanding.
When the Red Drug was used,
the percentage of Red Drug-
resistant parasites increases.
What do you notice when the
Blue Drug is used on the same
population instead.
• The percent of individual
parasites that are resistant
to Blue Drug increases.
NSEI 1.3.2 READING
ANTIMALARIAL DRUG RESISTANCE
When a combination of
drugs is used, resistance
stays low.
Remember that an
individual parasite can
have more than one trait
for resistance—some
individuals are resistant to
more than one drug.
NSEI 1.3.2 READING
ANTIMALARIAL DRUG RESISTANCE
Summarizing key points
• Using a single-drug treatment results in a shift in the distribution of traits in a malaria
population toward having more resistance to the drug used in that treatment.
• Once there is resistance to a drug, that drug may no longer effectively treat malaria.
• Using a combination of drugs is preferable to a treatment with a single drug.
TESTING FOR RESISTANCE
USING ONE DRUG
Use the MalariaMed DesignTool to observe the effects of single-drug treatments and to
discuss the pros and cons of each drug type. (15 min)
Design Tool activity.
It is important to isolate the different drugs
to understand their effects on the malaria
population over the ten years of the
MalariaMed model.
Play and discuss the MalariaMed Design
Tool Demo video.
TESTING FOR RESISTANCE
USING ONE DRUG
You are working to address each of the criteria to a greater or lesser extent, but the
constraint of avoiding an increase in the malaria parasite population is something that
must be accomplished.
The Global Health Organization won’t even consider a treatment design that causes
an overall increase in the parasite population.
Before you can determine which malaria treatments are ideal for addressing the
project criteria and this constraint, you must better understand the drugs you have
available.
This is different from the
word criteria.
It is important to prevent an
increase in the total parasite
population.
TESTING FOR RESISTANCE
USING ONE DRUG
Analyzing Single-Drug Treatments
sheets
You will record the results of these tests to
help with your research.
We will run the first test together as a team.
TESTING FOR RESISTANCE
USING ONE DRUG
Open Futura MalariaMed and we will model building and recording a single-drug
treatment for Drug A.
Set up and test a 7-day treatment of Drug A at small doses.
TESTING FOR RESISTANCE
USING ONE DRUG
Run the test…
The results for Percentage of Parasite
Population with High Resistance at the end of
10 years.
Record these values in the first table on your
sheets.
TESTING FOR RESISTANCE
USING ONE DRUG
Record the result for Total Parasite Population
on your sheet.
This result compares the size of the total
parasite population from year 0 to year 10, so
there was roughly no difference in the number
of individuals in the sample population.
No change
TESTING FOR RESISTANCE
USING ONE DRUG
Record the results for Patient Side Effects and Cost on
your sheet.
These results are directly related to the project criteria
and the constraint you must consider so your
treatments do not result in an increase in malaria
parasites.
While you should be concerned with…it is also
important to try to reduce the malaria parasite
population.
• minimizing drug resistance,
• minimizing patient side effects, and
• keeping costs low,
The ways to reduce the malaria parasite population and
the ways to keep resistance low can sometimes conflict.
Mild side effects, $5,250.
TESTING FOR RESISTANCE
USING ONE DRUG
How to analyze test result histograms
The histogram bars in each graph reflect the same
population of malaria parasites at year 10.
What traits for drug resistance exist in the
population at year 10?
• Almost all the parasites have high resistance to
Drug A, most have no resistance to Drug B and
Drug C, but a small number have some
resistance to these drugs.
TESTING FOR RESISTANCE
USING ONE DRUG
Show the percentage by selecting the % button.
This helps you look at the population in a different way
(by displaying the percentage that the number of
parasites represents in each bar).
Note that for each graph the total should equal 100%
because each histogram represents the same total
parasite population.
TESTING FOR RESISTANCE
USING ONE DRUG
Compare this distribution of traits to the
population at the beginning.
Move the time slider to year 0.
What do you notice?
The population started with 90% of no resistance to
Drug A and 10% of some resistance to Drug A.
For Drug B, 40% had no resistance, 40% had some
resistance, and 20% already had high resistance.
For Drug C, 20% had no resistance and 80% had some
resistance.
TESTING FOR RESISTANCE
USING ONE DRUG
Let’s talk through the observations for the
effect of 7 days of Drug A at small doses.
As you move the time slider to each year, note that the
total parasite population decreased during the first 5
years.
Record that observation on your sheets.
TESTING FOR RESISTANCE
USING ONE DRUG
Focus on Resistance to Drug A histogram.
Note when the majority (over 50%) of parasites in the
population had the trait for high resistance to Drug A
57% by year 5.
Record this in the observations section of your sheets.
TESTING FOR RESISTANCE
USING ONE DRUG
Once most of the parasites in the population
have high resistance to Drug A, the population
begins to increase.
Record that observation on your sheets.
What does this observation suggest?
The malaria treatment, using only Drug A, isn’t working
anymore to kill the parasites, so the individuals with
traits for resistance are more likely to produce
offspring with that same trait.
TESTING FOR RESISTANCE
USING ONE DRUG
Predict what would happen if you continue to
use this same malaria treatment and could see
the results forYear 15?Year 20?
The population would continue to increase because
continuing to use Drug A acts as a selection pressure
on the population, so individuals with traits for
resistance tend to survive and the trait becomes more
common.
TESTING FOR RESISTANCE
USING ONE DRUG
By year 10, 99% had high resistance to Drug A
and 1% had some resistance to Drug A.
Record this observation on your sheets.
TESTING FOR RESISTANCE
USING ONE DRUG
Focus on Resistance to Drug B histogram.
Review the years again and note that by year 10,
parasites with high resistance to Drug B had decreased
from 20% to 0%, and parasites with some resistance to
Drug B decreased from 40% to 6%.
Record this observation on your sheets.
What does this observation suggest?
By not using Drug B, parasites with the trait for
resistance to Drug B can be killed by using a different
drug.
TESTING FOR RESISTANCE
USING ONE DRUG
Focus on Resistance to Drug C histogram.
Review the years again and note that by year 10, there
were still 0% of the parasites with high resistance to
Drug C and parasites with some resistance to Drug C
decreased from 80% to 16%.
TESTING FOR RESISTANCE
USING ONE DRUG
In pairs - complete the remaining two tests and
discuss pros and cons.
Each partner will select one drug (B or C), complete
the test, and record the results.
Which drug will result in the highest percentage of high
resistance or which one will reach 50% high resistance
in the fewest number of years.
Share and record the results from your partners so
everyone has a complete analysis.
Discuss and record the pros and cons among the three
different drugs, using the results of each test.
TESTING FOR RESISTANCE
USING ONE DRUG
Debrief the results and connect back to the Dossier reading.
In each case, we isolated variables so each test was the same except for one thing.
• Each test used drugs for 7 days.
• Each test used small doses.
• We only varied the drug type in each test.
What are the pros and cons of each single-drug test?
Try to consider other ways you could better understand the effects of a single-drug.
• Try larger doses,
• Try fewer days.
TESTING FOR RESISTANCE
USING ONE DRUG
Debrief the results and connect back to the Dossier reading.
Tomorrow you will wrap-up your research by isolating for other variables to better
understand how the drugs affect the traits for drug resistance in the malaria population.
You may wish to point out that, as you just saw in the Design Tool, the constraint of killing
malaria parasites can be at odds with the criterion of minimizing drug resistance.
The best way to minimize drug resistance is to not give any drugs at all.
One of the challenges of this engineering problem is finding a good solution that addresses the
three criteria within the constraint of killing malaria.
NSEI 1.3 HOMEWORK
After-Hours Work:
Revisit Chapter 4 in the Dossier and revise or add new annotations.

Weitere ähnliche Inhalte

Was ist angesagt?

What is Antimicrobial Resistance?.pptx
What is Antimicrobial Resistance?.pptxWhat is Antimicrobial Resistance?.pptx
What is Antimicrobial Resistance?.pptxMD SALEEM
 
Antibiotics basics for clinicians
Antibiotics basics for cliniciansAntibiotics basics for clinicians
Antibiotics basics for cliniciansSatish Kamboj
 
Strongyloides stercoralis
Strongyloides stercoralisStrongyloides stercoralis
Strongyloides stercoralismohamed fathy
 
Antimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxAntimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxDr. Rakesh Prasad Sah
 
Antibiotic Resistance, Mechanism and Impact on society
Antibiotic Resistance, Mechanism and Impact on societyAntibiotic Resistance, Mechanism and Impact on society
Antibiotic Resistance, Mechanism and Impact on societyOORATHI SASIVARDHAN
 
molecular markers for antimalarial drug resistance
molecular markers for antimalarial drug resistancemolecular markers for antimalarial drug resistance
molecular markers for antimalarial drug resistanceAnil kumar
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse Chandan N
 
Fluroquinolones 01 01-19
Fluroquinolones 01 01-19Fluroquinolones 01 01-19
Fluroquinolones 01 01-19uma advani
 
Antimalarial drug efficacy and drug resistance(yemen)
Antimalarial drug efficacy and drug resistance(yemen)Antimalarial drug efficacy and drug resistance(yemen)
Antimalarial drug efficacy and drug resistance(yemen)Ghamdan Al Tahish
 
Manual QA Testing Interview Questions From H2KInfosys
Manual QA Testing Interview Questions From H2KInfosysManual QA Testing Interview Questions From H2KInfosys
Manual QA Testing Interview Questions From H2KInfosysH2kInfosys
 
Malaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug ResistanceMalaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug Resistancestompoutmalaria
 
Sulphonamides
SulphonamidesSulphonamides
SulphonamidesAMEERAN1
 
Tips for Writing Better Charters for Exploratory Testing Sessions by Michael...
 Tips for Writing Better Charters for Exploratory Testing Sessions by Michael... Tips for Writing Better Charters for Exploratory Testing Sessions by Michael...
Tips for Writing Better Charters for Exploratory Testing Sessions by Michael...TEST Huddle
 
Antimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitorsAntimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitorsAseenat Mansour
 

Was ist angesagt? (20)

What is Antimicrobial Resistance?.pptx
What is Antimicrobial Resistance?.pptxWhat is Antimicrobial Resistance?.pptx
What is Antimicrobial Resistance?.pptx
 
COVID-19 Vaccine Trials: Why we still need them?
COVID-19 Vaccine Trials: Why we still need them?COVID-19 Vaccine Trials: Why we still need them?
COVID-19 Vaccine Trials: Why we still need them?
 
Software Quality Assurance
Software Quality AssuranceSoftware Quality Assurance
Software Quality Assurance
 
Antiretroviral drugs
Antiretroviral drugsAntiretroviral drugs
Antiretroviral drugs
 
Antibiotics basics for clinicians
Antibiotics basics for cliniciansAntibiotics basics for clinicians
Antibiotics basics for clinicians
 
Strongyloides stercoralis
Strongyloides stercoralisStrongyloides stercoralis
Strongyloides stercoralis
 
Antimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxAntimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptx
 
8.ANTHELMINTIC DRUGS
8.ANTHELMINTIC DRUGS8.ANTHELMINTIC DRUGS
8.ANTHELMINTIC DRUGS
 
Antibiotic Resistance, Mechanism and Impact on society
Antibiotic Resistance, Mechanism and Impact on societyAntibiotic Resistance, Mechanism and Impact on society
Antibiotic Resistance, Mechanism and Impact on society
 
molecular markers for antimalarial drug resistance
molecular markers for antimalarial drug resistancemolecular markers for antimalarial drug resistance
molecular markers for antimalarial drug resistance
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse
 
Fluroquinolones 01 01-19
Fluroquinolones 01 01-19Fluroquinolones 01 01-19
Fluroquinolones 01 01-19
 
Antimalarial drug efficacy and drug resistance(yemen)
Antimalarial drug efficacy and drug resistance(yemen)Antimalarial drug efficacy and drug resistance(yemen)
Antimalarial drug efficacy and drug resistance(yemen)
 
Manual QA Testing Interview Questions From H2KInfosys
Manual QA Testing Interview Questions From H2KInfosysManual QA Testing Interview Questions From H2KInfosys
Manual QA Testing Interview Questions From H2KInfosys
 
Malaria 2003
Malaria 2003Malaria 2003
Malaria 2003
 
Antivirals
Antivirals Antivirals
Antivirals
 
Malaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug ResistanceMalaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug Resistance
 
Sulphonamides
SulphonamidesSulphonamides
Sulphonamides
 
Tips for Writing Better Charters for Exploratory Testing Sessions by Michael...
 Tips for Writing Better Charters for Exploratory Testing Sessions by Michael... Tips for Writing Better Charters for Exploratory Testing Sessions by Michael...
Tips for Writing Better Charters for Exploratory Testing Sessions by Michael...
 
Antimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitorsAntimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitors
 

Ähnlich wie Understanding Drug Resistance

Dr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. Reality
Dr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. RealityDr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. Reality
Dr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. RealityJohn Blue
 
Changing treatment and drug resistance
Changing treatment and drug resistanceChanging treatment and drug resistance
Changing treatment and drug resistanceITPCMENA
 
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityDr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityJohn Blue
 
Rheumatoid arthritis and management
Rheumatoid arthritis and managementRheumatoid arthritis and management
Rheumatoid arthritis and managementHarsh shaH
 
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityDr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityJohn Blue
 
Antimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobindaAntimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobindaGOBINDA PRASAD PRADHAN
 
Dr. Nuala O'Connor, GP Elmwood Medical Practice
Dr. Nuala O'Connor, GP Elmwood Medical PracticeDr. Nuala O'Connor, GP Elmwood Medical Practice
Dr. Nuala O'Connor, GP Elmwood Medical PracticeInvestnet
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & ArnabArghya Chowdhury
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxAhmed Mshari
 
Jatin singla project ppt
Jatin singla project pptJatin singla project ppt
Jatin singla project pptjatin singla
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxSaheedAbdulbasit
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxSaheedAbdulbasit
 
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdfCase Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdfbkbk37
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxodiliagilby
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxavaforman16457
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardshipMohd Saif Khan
 
Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020SoumyadipGhosh19
 
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 General prescribing guidelines for Pediatrics geriatrics pregnancy lactating... General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...Koppala RVS Chaitanya
 
Negative impacts of antibiotics
Negative impacts of antibioticsNegative impacts of antibiotics
Negative impacts of antibioticsMshaan Albgomi
 

Ähnlich wie Understanding Drug Resistance (20)

Dr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. Reality
Dr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. RealityDr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. Reality
Dr. Richard Raymond - Food Safety & Antibiotics: Perceptions vs. Reality
 
Changing treatment and drug resistance
Changing treatment and drug resistanceChanging treatment and drug resistance
Changing treatment and drug resistance
 
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityDr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
 
Rheumatoid arthritis and management
Rheumatoid arthritis and managementRheumatoid arthritis and management
Rheumatoid arthritis and management
 
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityDr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. Reality
 
Antimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobindaAntimicrobial resistance ppt by dr. gobinda
Antimicrobial resistance ppt by dr. gobinda
 
Dr. Nuala O'Connor, GP Elmwood Medical Practice
Dr. Nuala O'Connor, GP Elmwood Medical PracticeDr. Nuala O'Connor, GP Elmwood Medical Practice
Dr. Nuala O'Connor, GP Elmwood Medical Practice
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & Arnab
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
 
Jatin singla project ppt
Jatin singla project pptJatin singla project ppt
Jatin singla project ppt
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
 
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdfCase Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docx
 
You are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docxYou are an employee at Novartis. The company is currently addres.docx
You are an employee at Novartis. The company is currently addres.docx
 
JPDS
JPDSJPDS
JPDS
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020
 
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 General prescribing guidelines for Pediatrics geriatrics pregnancy lactating... General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 
Negative impacts of antibiotics
Negative impacts of antibioticsNegative impacts of antibiotics
Negative impacts of antibiotics
 

Mehr von dwinter1

Writing Design Decisions
Writing Design DecisionsWriting Design Decisions
Writing Design Decisionsdwinter1
 
Considering Design Decisions
Considering Design DecisionsConsidering Design Decisions
Considering Design Decisionsdwinter1
 
Writing A Scientific Argument
Writing A Scientific ArgumentWriting A Scientific Argument
Writing A Scientific Argumentdwinter1
 
Engaging In A Science Seminar
Engaging In A Science SeminarEngaging In A Science Seminar
Engaging In A Science Seminardwinter1
 
Examining Evidence About Sticklebacks
Examining Evidence About SticklebacksExamining Evidence About Sticklebacks
Examining Evidence About Sticklebacksdwinter1
 
Wrapping Up The Newt Mystery
Wrapping Up The Newt MysteryWrapping Up The Newt Mystery
Wrapping Up The Newt Mysterydwinter1
 
Mutations In a Population
Mutations In a PopulationMutations In a Population
Mutations In a Populationdwinter1
 
Introduction to Mutations
Introduction to MutationsIntroduction to Mutations
Introduction to Mutationsdwinter1
 
Reviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural SelectionReviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural Selectiondwinter1
 
The Deadly Dare
The Deadly DareThe Deadly Dare
The Deadly Daredwinter1
 
Reasoning About The Newt Mystery
Reasoning About The Newt MysteryReasoning About The Newt Mystery
Reasoning About The Newt Mysterydwinter1
 
Survival and Reproduction
Survival and ReproductionSurvival and Reproduction
Survival and Reproductiondwinter1
 
Reproduction and Traits
Reproduction and TraitsReproduction and Traits
Reproduction and Traitsdwinter1
 
Explaining Changes in Trait Distribution
Explaining Changes in Trait DistributionExplaining Changes in Trait Distribution
Explaining Changes in Trait Distributiondwinter1
 
Adaptive Traits
Adaptive TraitsAdaptive Traits
Adaptive Traitsdwinter1
 
Investigating Changes In Trait Distribution
Investigating Changes In Trait DistributionInvestigating Changes In Trait Distribution
Investigating Changes In Trait Distributiondwinter1
 
Exploring Variation and Distribution in Populations
Exploring Variation and Distribution in PopulationsExploring Variation and Distribution in Populations
Exploring Variation and Distribution in Populationsdwinter1
 
Natural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous NewtNatural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous Newtdwinter1
 
Writing an Argument About the Channel on Mars
Writing an Argument About the Channel on MarsWriting an Argument About the Channel on Mars
Writing an Argument About the Channel on Marsdwinter1
 
Reasoning About Evidence From Mars
Reasoning About Evidence From MarsReasoning About Evidence From Mars
Reasoning About Evidence From Marsdwinter1
 

Mehr von dwinter1 (20)

Writing Design Decisions
Writing Design DecisionsWriting Design Decisions
Writing Design Decisions
 
Considering Design Decisions
Considering Design DecisionsConsidering Design Decisions
Considering Design Decisions
 
Writing A Scientific Argument
Writing A Scientific ArgumentWriting A Scientific Argument
Writing A Scientific Argument
 
Engaging In A Science Seminar
Engaging In A Science SeminarEngaging In A Science Seminar
Engaging In A Science Seminar
 
Examining Evidence About Sticklebacks
Examining Evidence About SticklebacksExamining Evidence About Sticklebacks
Examining Evidence About Sticklebacks
 
Wrapping Up The Newt Mystery
Wrapping Up The Newt MysteryWrapping Up The Newt Mystery
Wrapping Up The Newt Mystery
 
Mutations In a Population
Mutations In a PopulationMutations In a Population
Mutations In a Population
 
Introduction to Mutations
Introduction to MutationsIntroduction to Mutations
Introduction to Mutations
 
Reviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural SelectionReviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural Selection
 
The Deadly Dare
The Deadly DareThe Deadly Dare
The Deadly Dare
 
Reasoning About The Newt Mystery
Reasoning About The Newt MysteryReasoning About The Newt Mystery
Reasoning About The Newt Mystery
 
Survival and Reproduction
Survival and ReproductionSurvival and Reproduction
Survival and Reproduction
 
Reproduction and Traits
Reproduction and TraitsReproduction and Traits
Reproduction and Traits
 
Explaining Changes in Trait Distribution
Explaining Changes in Trait DistributionExplaining Changes in Trait Distribution
Explaining Changes in Trait Distribution
 
Adaptive Traits
Adaptive TraitsAdaptive Traits
Adaptive Traits
 
Investigating Changes In Trait Distribution
Investigating Changes In Trait DistributionInvestigating Changes In Trait Distribution
Investigating Changes In Trait Distribution
 
Exploring Variation and Distribution in Populations
Exploring Variation and Distribution in PopulationsExploring Variation and Distribution in Populations
Exploring Variation and Distribution in Populations
 
Natural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous NewtNatural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous Newt
 
Writing an Argument About the Channel on Mars
Writing an Argument About the Channel on MarsWriting an Argument About the Channel on Mars
Writing an Argument About the Channel on Mars
 
Reasoning About Evidence From Mars
Reasoning About Evidence From MarsReasoning About Evidence From Mars
Reasoning About Evidence From Mars
 

Kürzlich hochgeladen

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIShubhangi Sonawane
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 

Kürzlich hochgeladen (20)

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 

Understanding Drug Resistance

  • 2. Read the daily message and record notes of important points and deliverables. (5 min) Open your pinned Daily Message Notes • Add the today’s date and the subject of the message (Causes of Drug Resistance) at the top of the note. • Add (Copy/Paste) summary of deliverables and/or important information under heading. NSEI 1.3.1 WARM-UP
  • 3. NSEI REVIEW NS IN PARASITES Interns re-watch a video to review what you have learned about parasite populations and antimalarial drugs. (5 min)
  • 4. What have you learned about antimalarial drug resistance? Share with your table. NSEI REVIEW NS IN PARASITES Key Points: • Antimalarial drugs act as a selection pressure on a population of malaria parasites. • Every time a malaria parasite reproduces, a mutation that could lead to resistance to a drug has a chance to occur. • A mutation can result in a new trait that is adaptive or non-adaptive, or the mutation may have no noticeable effect. • Parasites with the adaptive trait of drug resistance will be more likely to survive the exposure to that drug and be able to reproduce and pass this trait to their offspring.This shifts the distribution of traits in that population, so that many more individual parasites have resistance for that drug. • In the presence of this selection pressure, the distribution of traits in a population of malaria parasites may shift toward increased drug resistance.
  • 5. NSEI 1.3.2 READING ANTIMALARIAL DRUG RESISTANCE Interns actively read from the Dossier to learn more about how single-drug and combination treatments affect drug resistance. (25 min) Open the Futura Biomedical Engineer’s Dossier. Selecting the link in the Daily Message and use the table of contents to navigate to Ch 4: “Antimalarial Drug Resistance.” • Today’s research connects what you have learned about antimalarial drugs as a selection pressure to how drug resistance develops in a diverse population of parasites. • You should make annotations that help answer the question on the board: How do malaria treatments influence drug resistance?
  • 6. NSEI 1.3.2 READING ANTIMALARIAL DRUG RESISTANCE Read and annotate independently. Actively read and annotate Ch.4 “Antimalarial Drug Resistance” of the Dossier. • Carefully review the diagrams and captions, and to look at the glossary if you need more support with engineering and project terms.
  • 7. NSEI 1.3.2 READING ANTIMALARIAL DRUG RESISTANCE Share and discuss your annotations with your partner. Talk about what you have learned from the chapter. What ideas do you have about how antimalarial drugs influence drug resistance?
  • 8. NSEI 1.3.2 READING ANTIMALARIAL DRUG RESISTANCE Let’s review the diagrams to check for understanding. When the Red Drug was used, the percentage of Red Drug- resistant parasites increases. What do you notice when the Blue Drug is used on the same population instead. • The percent of individual parasites that are resistant to Blue Drug increases.
  • 9. NSEI 1.3.2 READING ANTIMALARIAL DRUG RESISTANCE When a combination of drugs is used, resistance stays low. Remember that an individual parasite can have more than one trait for resistance—some individuals are resistant to more than one drug.
  • 10. NSEI 1.3.2 READING ANTIMALARIAL DRUG RESISTANCE Summarizing key points • Using a single-drug treatment results in a shift in the distribution of traits in a malaria population toward having more resistance to the drug used in that treatment. • Once there is resistance to a drug, that drug may no longer effectively treat malaria. • Using a combination of drugs is preferable to a treatment with a single drug.
  • 11. TESTING FOR RESISTANCE USING ONE DRUG Use the MalariaMed DesignTool to observe the effects of single-drug treatments and to discuss the pros and cons of each drug type. (15 min) Design Tool activity. It is important to isolate the different drugs to understand their effects on the malaria population over the ten years of the MalariaMed model. Play and discuss the MalariaMed Design Tool Demo video.
  • 12. TESTING FOR RESISTANCE USING ONE DRUG You are working to address each of the criteria to a greater or lesser extent, but the constraint of avoiding an increase in the malaria parasite population is something that must be accomplished. The Global Health Organization won’t even consider a treatment design that causes an overall increase in the parasite population. Before you can determine which malaria treatments are ideal for addressing the project criteria and this constraint, you must better understand the drugs you have available. This is different from the word criteria. It is important to prevent an increase in the total parasite population.
  • 13. TESTING FOR RESISTANCE USING ONE DRUG Analyzing Single-Drug Treatments sheets You will record the results of these tests to help with your research. We will run the first test together as a team.
  • 14. TESTING FOR RESISTANCE USING ONE DRUG Open Futura MalariaMed and we will model building and recording a single-drug treatment for Drug A. Set up and test a 7-day treatment of Drug A at small doses.
  • 15. TESTING FOR RESISTANCE USING ONE DRUG Run the test… The results for Percentage of Parasite Population with High Resistance at the end of 10 years. Record these values in the first table on your sheets.
  • 16. TESTING FOR RESISTANCE USING ONE DRUG Record the result for Total Parasite Population on your sheet. This result compares the size of the total parasite population from year 0 to year 10, so there was roughly no difference in the number of individuals in the sample population. No change
  • 17. TESTING FOR RESISTANCE USING ONE DRUG Record the results for Patient Side Effects and Cost on your sheet. These results are directly related to the project criteria and the constraint you must consider so your treatments do not result in an increase in malaria parasites. While you should be concerned with…it is also important to try to reduce the malaria parasite population. • minimizing drug resistance, • minimizing patient side effects, and • keeping costs low, The ways to reduce the malaria parasite population and the ways to keep resistance low can sometimes conflict. Mild side effects, $5,250.
  • 18. TESTING FOR RESISTANCE USING ONE DRUG How to analyze test result histograms The histogram bars in each graph reflect the same population of malaria parasites at year 10. What traits for drug resistance exist in the population at year 10? • Almost all the parasites have high resistance to Drug A, most have no resistance to Drug B and Drug C, but a small number have some resistance to these drugs.
  • 19. TESTING FOR RESISTANCE USING ONE DRUG Show the percentage by selecting the % button. This helps you look at the population in a different way (by displaying the percentage that the number of parasites represents in each bar). Note that for each graph the total should equal 100% because each histogram represents the same total parasite population.
  • 20. TESTING FOR RESISTANCE USING ONE DRUG Compare this distribution of traits to the population at the beginning. Move the time slider to year 0. What do you notice? The population started with 90% of no resistance to Drug A and 10% of some resistance to Drug A. For Drug B, 40% had no resistance, 40% had some resistance, and 20% already had high resistance. For Drug C, 20% had no resistance and 80% had some resistance.
  • 21. TESTING FOR RESISTANCE USING ONE DRUG Let’s talk through the observations for the effect of 7 days of Drug A at small doses. As you move the time slider to each year, note that the total parasite population decreased during the first 5 years. Record that observation on your sheets.
  • 22. TESTING FOR RESISTANCE USING ONE DRUG Focus on Resistance to Drug A histogram. Note when the majority (over 50%) of parasites in the population had the trait for high resistance to Drug A 57% by year 5. Record this in the observations section of your sheets.
  • 23. TESTING FOR RESISTANCE USING ONE DRUG Once most of the parasites in the population have high resistance to Drug A, the population begins to increase. Record that observation on your sheets. What does this observation suggest? The malaria treatment, using only Drug A, isn’t working anymore to kill the parasites, so the individuals with traits for resistance are more likely to produce offspring with that same trait.
  • 24. TESTING FOR RESISTANCE USING ONE DRUG Predict what would happen if you continue to use this same malaria treatment and could see the results forYear 15?Year 20? The population would continue to increase because continuing to use Drug A acts as a selection pressure on the population, so individuals with traits for resistance tend to survive and the trait becomes more common.
  • 25. TESTING FOR RESISTANCE USING ONE DRUG By year 10, 99% had high resistance to Drug A and 1% had some resistance to Drug A. Record this observation on your sheets.
  • 26. TESTING FOR RESISTANCE USING ONE DRUG Focus on Resistance to Drug B histogram. Review the years again and note that by year 10, parasites with high resistance to Drug B had decreased from 20% to 0%, and parasites with some resistance to Drug B decreased from 40% to 6%. Record this observation on your sheets. What does this observation suggest? By not using Drug B, parasites with the trait for resistance to Drug B can be killed by using a different drug.
  • 27. TESTING FOR RESISTANCE USING ONE DRUG Focus on Resistance to Drug C histogram. Review the years again and note that by year 10, there were still 0% of the parasites with high resistance to Drug C and parasites with some resistance to Drug C decreased from 80% to 16%.
  • 28. TESTING FOR RESISTANCE USING ONE DRUG In pairs - complete the remaining two tests and discuss pros and cons. Each partner will select one drug (B or C), complete the test, and record the results. Which drug will result in the highest percentage of high resistance or which one will reach 50% high resistance in the fewest number of years. Share and record the results from your partners so everyone has a complete analysis. Discuss and record the pros and cons among the three different drugs, using the results of each test.
  • 29. TESTING FOR RESISTANCE USING ONE DRUG Debrief the results and connect back to the Dossier reading. In each case, we isolated variables so each test was the same except for one thing. • Each test used drugs for 7 days. • Each test used small doses. • We only varied the drug type in each test. What are the pros and cons of each single-drug test? Try to consider other ways you could better understand the effects of a single-drug. • Try larger doses, • Try fewer days.
  • 30. TESTING FOR RESISTANCE USING ONE DRUG Debrief the results and connect back to the Dossier reading. Tomorrow you will wrap-up your research by isolating for other variables to better understand how the drugs affect the traits for drug resistance in the malaria population. You may wish to point out that, as you just saw in the Design Tool, the constraint of killing malaria parasites can be at odds with the criterion of minimizing drug resistance. The best way to minimize drug resistance is to not give any drugs at all. One of the challenges of this engineering problem is finding a good solution that addresses the three criteria within the constraint of killing malaria.
  • 31. NSEI 1.3 HOMEWORK After-Hours Work: Revisit Chapter 4 in the Dossier and revise or add new annotations.